Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Net Income (2016 - 2025)

Nutex Health's Net Income history spans 13 years, with the latest figure at $16.6 million for Q4 2025.

  • For Q4 2025, Net Income fell 83.31% year-over-year to $16.6 million; the TTM value through Dec 2025 reached $180.4 million, up 90.24%, while the annual FY2025 figure was $180.4 million, 90.24% up from the prior year.
  • Net Income for Q4 2025 was $16.6 million at Nutex Health, down from $103.4 million in the prior quarter.
  • Across five years, Net Income topped out at $103.4 million in Q3 2025 and bottomed at -$422.9 million in Q3 2022.
  • The 4-year median for Net Income is -$2.4 million (2023), against an average of -$12.5 million.
  • The largest annual shift saw Net Income tumbled 159.99% in 2023 before it soared 8259.23% in 2025.
  • A 4-year view of Net Income shows it stood at -$10.7 million in 2022, then tumbled by 159.99% to -$27.7 million in 2023, then soared by 459.07% to $99.5 million in 2024, then plummeted by 83.31% to $16.6 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Net Income are $16.6 million (Q4 2025), $103.4 million (Q3 2025), and $16.1 million (Q2 2025).